CGPCS
ONC

Capital Group Private Client Services’s BeOne Medicines Ltd ONC Stock Holding History

Capital Group Private Client Services’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.61M Sell
23,206
-5,450
-19% -$1.61M 0.09% 89
2026
Q1 		$8.51M Sell
28,656
-13,127
-31% -$4.25M 0.14% 75
2025
Q4 		$12.7M Sell
41,783
-1,945
-4% -$637K 0.2% 67
2025
Q3 		$14.9M Sell
43,728
-104,885
-71% -$31.8M 0.25% 58
2025
Q2 		$36M Sell
148,613
-3,543
-2% -$869K 0.31% 76
2025
Q1 		$41.4M Sell
152,156
-7,141
-4% -$1.67M 0.4% 66
2024
Q4 		$29.4M Sell
159,297
-23,602
-13% -$4.82M 0.27% 88
2024
Q3 		$41.1M Sell
182,899
-9,941
-5% -$1.79M 0.39% 68
2024
Q2 		$27.5M Sell
192,840
-15,960
-8% -$2.46M 0.28% 95
2024
Q1 		$32.7M Buy
208,800
+11,579
+6% +$1.86M 0.33% 84
2023
Q4 		$35.6M Sell
197,221
-25,950
-12% -$4.69M 0.37% 82
2023
Q3 		$40.1M Sell
223,171
-4,330
-2% -$857K 0.49% 67
2023
Q2 		$40.6M Sell
227,501
-18,638
-8% -$4.29M 0.48% 71
2023
Q1 		$53.1M Sell
246,139
-11,749
-5% -$2.82M 0.66% 51
2022
Q4 		$56.7M Sell
257,888
-5,165
-2% -$947K 0.72% 44
2022
Q3 		$35.5M Sell
263,053
-2,689
-1% -$462K 0.5% 68
2022
Q2 		$43M Sell
265,742
-9,455
-3% -$1.48M 0.56% 58
2022
Q1 		$51.9M Buy
275,197
+117,231
+74% +$24.9M 0.57% 56
2021
Q4 		$42.8M Sell
157,966
-4,014
-2% -$1.36M 0.46% 70
2021
Q3 		$58.8M Buy
+161,980
New +$53M 0.68% 52

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Capital Group Private Client Services's ONC Position: Q2 2026 in Review

Capital Group Private Client Services reduced its BeOne Medicines Ltd (ONC) stake by 19% in Q2 2026, selling an estimated $1.61M and leaving 23,206 shares worth $6.61M. The position accounts for 0.09% of the portfolio, ranked #89.

Capital Group Private Client Services first reported a position in ONC in Q3 2021 and has held it in 20 quarters since. The position peaked at $58.8M in Q3 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Capital Group Private Client Services held 23,206 shares of BeOne Medicines Ltd worth $6.61M as of Q2 2026.
  • Capital Group Private Client Services sold 5,450 BeOne Medicines Ltd shares in Q2 2026, an estimated $1.61M.
  • BeOne Medicines Ltd made up 0.09% of Capital Group Private Client Services's portfolio in Q2 2026, its #89 holding.
  • Capital Group Private Client Services first reported a position in BeOne Medicines Ltd in Q3 2021 and has held it in 20 quarters since.
  • Capital Group Private Client Services's BeOne Medicines Ltd position peaked at $58.8M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Capital Group Private Client Services's 13F filing for Q2 2026, filed 12 Aug 2026.